Heterogeneity and cardiac arrhythmias: An overview

Heart Rhythm

Volumn 4, Issue 7, 2007, Pages 964-972

  Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Brugada syndrome; Electrophysiology; Long QT syndrome; Polymorphic ventricular tachycardia; Short QT syndrome

Indexed keywords

AMIODARONE; BINDING PROTEIN; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CATECHOLAMINE; CAVEOLIN; CAVEOLIN 3; CHROMANOL 293B; CISAPRIDE; ISOPRENALINE; PENTOBARBITAL; POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; POTASSIUM CHANNEL KCNQ1; RYANODINE RECEPTOR 2; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

ACTION POTENTIAL; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BRUGADA SYNDROME; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHANNELOPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOCARDIUM; EPICARDIUM; GENE MUTATION; HEART ARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE WALL; HUMAN; HYPOTHESIS; LONG QT SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QT PROLONGATION; SHORT QT SYNDROME; SUDDEN DEATH;

ACTION POTENTIALS; ARRHYTHMIA; ELECTROPHYSIOLOGY; HEART; HEART CONDUCTION SYSTEM; HUMANS;

EID: 34250763837     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2007.03.036     Document Type: Article

References (104)

1. Han J., and Moe G.K. Nonuniform recovery of excitability in ventricular muscle. Circ Res 14 (1964) 44-60
2. Han J., Millet D., Chizzonitti B., and Moe G.K. Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate. Am Heart J 71 (1966) 481-487
3. Moe G.K., Rheinboldt W.C., and Abildskov J.A. A computer model of atrial fibrillation. Am Heart J 67 (1964) 200-220
4. Schwartz P.J. The idiopathic long QT syndrome: progress and questions. Am Heart J 109 (1985) 399-411
5. Moss A.J., Schwartz P.J., Crampton R.S., Tzivoni D., Locati E.H., MacCluer J.W., Hall W.J., Weitkamp L.R., Vincent G.M., Garson A., Robinson J.L., Benhorin J., and Choi S. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 84 (1991) 1136-1144
6. Zipes D.P. The long QT interval syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 84 (1991) 1414-1419
7. Wang Q., Shen J., Splawski I., Atkinson D.L., Li Z.Z., Robinson J.L., Moss A.J., Towbin J.A., and Keating M.T. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 (1995) 805-811
8. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., Song L.S., Haurogne K., Kyndt F., Ali M.E., Rogers T.B., Lederer W.J., Escande D., Le Marec H., and Bennett V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421 (2003) 634-639
9. Plaster N.M., Tawil R., Tristani-Firouzi M., Canun S., Bendahhou S., Tsunoda A., Donaldson M.R., Iannaccone S.T., Brunt E., Barohn R., Clark J., Deymeer F., George Jr. A.L., Fish F.A., Hahn A., Nitu A., Ozdemir C., Serdaroglu P., Subramony S.H., Wolfe G., Fu Y.H., and Ptacek L.J. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 (2001) 511-519
10. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., and Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 (1995) 795-803
11. Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M., Van Raay T.J., Shen J., Timothy K.W., Vincent G.M., De Jager T., Schwartz P.J., Towbin J.A., Moss A.J., Atkinson D.L., Landes G.M., Connors T.D., and Keating M.T. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12 (1996) 17-23
12. Ks function. Nat Genet 17 (1997) 338-340
13. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., Napolitano C., Schwartz P.J., Joseph R.M., Condouris K., Tager-Flusberg H., Priori S.G., Sanguinetti M.C., and Keating M.T. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119 (2004) 19-31
14. Vatta M., Ackerman M.J., Ye B., Makielski J.C., Ughanze E.E., Taylor E.W., Tester D.J., Balijepalli R.C., Foell J.D., Li Z., Kamp T.J., and Towbin J.A. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114 (2006) 2104-2112
15. Domingo A.M., Kaku T., Tester D.J., Torres P.I., Itty A., Ye B., Valdivia C.R., Makielski J.C., Quintero S.C., Luna T.T., and Ackerman M.J. Sodium channel β4 subunit mutation causes congenital long QT syndrome. Heart Rhythm 3 (2006) S34
16. Bednar M.M., Harrigan E.P., Anziano R.J., Camm A.J., and Ruskin J.N. The QT interval. Prog Cardiovasc Dis 43 (2001) 1-45
17. Tomaselli G.F., and Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42 (1999) 270-283
18. Sipido K.R., Volders P.G., De Groot S.H., Verdonck F., Van de W.F., Wellens H.J., and Vos M.A. Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation 102 (2000) 2137-2144
19. Volders P.G., Sipido K.R., Vos M.A., Spatjens R.L., Leunissen J.D., Carmeliet E., and Wellens H.J. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 100 (1999) 2455-2461
20. Undrovinas A.I., Maltsev V.A., and Sabbah H.N. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci 55 (1999) 494-505
21. Maltsev V.A., Sabbah H.N., Higgins R.S., Silverman N., Lesch M., and Undrovinas A.I. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98 (1998) 2545-2552
22. Roden D.M. Long QT syndrome: reduced repolarization reserve and the genetic link. J Intern Med 259 (2006) 59-69
23. Belardinelli L., Antzelevitch C., and Vos M.A. Assessing predictors of drug-induced torsade de pointes. Trends Pharmacol Sci 24 (2003) 619-625
24. Antzelevitch C., and Shimizu W. Cellular mechanisms underlying the Long QT syndrome. Curr Opin Cardiol 17 (2002) 43-51
25. Shimizu W., and Antzelevitch C. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation 102 (2000) 706-712
26. Shimizu W., and Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long QT syndrome: effects of β-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. Circulation 98 (1998) 2314-2322
27. Shimizu W., and Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 96 (1997) 2038-2047
28. Shimizu W., and Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 35 (2000) 778-786
29. Ueda N., Zipes D.P., and Wu J. Prior ischemia enhances arrhythmogenicity in isolated canine ventricular wedge model of long QT 3. Cardiovasc Res 63 (2004) 69-76
30. Ueda N., Zipes D.P., and Wu J. Functional and transmural modulation of M cell behavior in canine ventricular wall. Am J Physiol Heart Circ Physiol 287 (2004) H2569-H2575
31. Sicouri S., and Antzelevitch C. A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. Circ Res 68 (1991) 1729-1741
32. Antzelevitch C., Shimizu W., Yan G.X., Sicouri S., Weissenburger J., Nesterenko V.V., Burashnikov A., Di Diego J.M., Saffitz J., and Thomas G.P. The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart. J Cardiovasc Electrophysiol 10 (1999) 1124-1152
33. Anyukhovsky E.P., Sosunov E.A., Gainullin R.Z., and Rosen M.R. The controversial M cell. J Cardiovasc Electrophysiol 10 (1999) 244-260
34. Sicouri S., Fish J., and Antzelevitch C. Distribution of M cells in the canine ventricle. J Cardiovasc Electrophysiol 5 (1994) 824-837
35. Yan G.X., Shimizu W., and Antzelevitch C. Characteristics and distribution of M cells in arterially-perfused canine left ventricular wedge preparations. Circulation 98 (1998) 1921-1927
36. Poelzing S., Akar F.G., Baron E., and Rosenbaum D.S. Heterogeneous connexin43 expression produces electrophysiological heterogeneities across ventricular wall. Am J Physiol Heart Circ Physiol 286 (2004) H2001-H2009
37. Yamada K.A., Kanter E.M., Green K.G., and Saffitz J.E. Transmural distribution of connexins in rodent hearts. J Cardiovasc Electrophysiol 15 (2004) 710-715
38. Viswanathan P.C., and Rudy Y. Cellular arrhythmogenic effects of the congenital and acquired long QT syndrome in the heterogeneous myocardium. Circulation 101 (2000) 1192-1198
39. Zygmunt A.C., Eddlestone G.T., Thomas G.P., Nesterenko V.V., and Antzelevitch C. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol 281 (2001) H689-H697
40. Ks) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. Circ Res 76 (1995) 351-365
41. Na-Ca contributes to electrical heterogeneity within the canine ventricle. Am J Physiol 278 (2000) H1671-H1678
42. Yan G.X., and Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 98 (1998) 1928-1936
43. Emori T., and Antzelevitch C. Cellular basis for complex T waves and arrhythmic activity following combined I(Kr) and I(Ks) block. J Cardiovasc Electrophysiol 12 (2001) 1369-1378
44. Wolk R., Stec S., and Kulakowski P. Extrasystolic beats affect transmural electrical dispersion during programmed electrical stimulation. Eur J Clinical Invest 31 (2001) 293-301
45. Tanabe Y., Inagaki M., Kurita T., Nagaya N., Taguchi A., Suyama K., Aihara N., Kamakura S., Sunagawa K., Nakamura K., Ohe T., Towbin J.A., Priori S.G., and Shimizu W. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol 37 (2001) 911-919
46. Frederiks J., Swenne C.A., Kors J.A., van Herpen G., Maan A.C., Levert J.V., Schalij M.J., and Bruschke A.V. Within-subject electrocardiographic differences at equal heart rates: role of the autonomic nervous system. Pflugers Arch 441 (2001) 717-724
47. Shimizu M., Ino H., Okeie K., Yamaguchi M., Nagata M., Hayashi K., Itoh H., Iwaki T., Oe K., Konno T., and Mabuchi H. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 25 (2002) 335-339
48. Takenaka K., Ai T., Shimizu W., Kobori A., Ninomiya T., Otani H., Kubota T., Takaki H., Kamakura S., and Horie M. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 107 (2003) 838-844
49. Watanabe N., Kobayashi Y., Tanno K., Miyoshi F., Asano T., Kawamura M., Mikami Y., Adachi T., Ryu S., Miyata A., and Katagiri T. Transmural dispersion of repolarization and ventricular tachyarrhythmias. J Electrocardiol 37 (2004) 191-200
50. Schwartz P.J., Priori S.G., Spazzolini C., Moss A.J., Vincent G.M., Napolitano C., Denjoy I., Guicheney P., Breithardt G., Keating M.T., Towbin J.A., Beggs A.H., Brink P., Wilde A.A., Toivonen L., Zareba W., Robinson J.L., Timothy K.W., Corfield V., Wattanasirichaigoon D., Corbett C., Haverkamp W., Schulze-Bahr E., Lehmann M.H., Schwartz K., Coumel P., and Bloise R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 89-95
51. Yamaguchi M., Shimizu M., Ino H., Terai H., Uchiyama K., Oe K., Mabuchi T., Konno T., Kaneda T., and Mabuchi H. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clin Sci (Lond) 105 (2003) 671-676
52. Antzelevitch C., Belardinelli L., Zygmunt A.C., Burashnikov A., Di Diego J.M., Fish J.M., Cordeiro J.M., and Thomas G.P. Electrophysiologic effects of ranolazine: a novel anti-anginal agent with antiarrhythmic properties. Circulation 110 (2004) 904-910
53. Di Diego J.M., Belardinelli L., and Antzelevitch C. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation. Circulation 108 (2003) 1027-1033
54. Antzelevitch C. Drug-induced channelopathies. In: Zipes D.P., and Jalife J. (Eds). Cardiac Electrophysiology: From Cell to Bedside. Fourth Edition (2004), WB Saunders, New York 151-157
55. Fenichel R.R., Malik M., Antzelevitch C., Sanguinetti M.C., Roden D.M., Priori S.G., Ruskin J.N., Lipicky R.J., and Cantilena L.R. Drug-induced torsade de pointes and implications for drug development. J Cardiovasc Electrophysiol 15 (2004) 475-495
56. Li G.R., Feng J., Yue L., and Carrier M. Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle. Am J Physiol 275 (1998) H369-H377
57. Sicouri S., Moro S., Litovsky S.H., Elizari M.V., and Antzelevitch C. Chronic amiodarone reduces transmural dispersion of repolarization in the canine heart. J Cardiovasc Electrophysiol 8 (1997) 1269-1279
58. van Opstal J.M., Schoenmakers M., Verduyn S.C., De Groot S.H., Leunissen J.D., Der Hulst F.F., Molenschot M.M., Wellens H.J., and Vos M.A. Chronic Amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome. Circulation 104 (2001) 2722-2727
59. Shimizu W., McMahon B., and Antzelevitch C. Sodium pentobarbital reduces transmural dispersion of repolarization and prevents torsade de pointes in models of acquired and congenital long QT syndrome. J Cardiovasc Electrophysiol 10 (1999) 156-164
60. Di Diego J.M., Belardinelli L., and Antzelevitch C. Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation. Circulation 108 (2003) 1027-1033
61. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 20 (1992) 1391-1396
62. Brugada R., Brugada J., Antzelevitch C., Kirsch G.E., Potenza D., Towbin J.A., and Brugada P. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 101 (2000) 510-515
63. Shimizu W., Antzelevitch C., Suyama K., Kurita T., Taguchi A., Aihara N., Takaki H., Sunagawa K., and Kamakura S. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 11 (2000) 1320-1329
64. Priori S.G., Napolitano C., Gasparini M., Pappone C., Della B.P., Brignole M., Giordano U., Giovannini T., Menozzi C., Bloise R., Crotti L., Terreni L., and Schwartz P.J. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 102 (2000) 2509-2515
65. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., Potenza D., Moya A., Borggrefe M., Breithardt G., Ortiz-Lopez R., Wang Z., Antzelevitch C., O'Brien R.E., Schultze-Bahr E., Keating M.T., Towbin J.A., and Wang Q. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
66. Antzelevitch C., Brugada P., Brugada J., and Brugada R. The Brugada Syndrome: From Bench to Bedside (2005), Blackwell Futura, Oxford 1-220
67. Schulze-Bahr E., Eckardt L., Breithardt G., Seidl K., Wichter T., Wolpert C., Borggrefe M., and Haverkamp W. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat 21 (2003) 651-652
68. Hong K., Guerchicoff A., Pollevick G.D., Oliva A., Dumaine R., de Zutter M., Burashnikov E., Wu Y.S., Brugada J., Brugada P., and Brugada R. Cryptic 5′ splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol 38 (2005) 555-560
69. Bezzina C.R., Shimizu W., Yang P., Koopmann T.T., Tanck M.W., Miyamoto Y., Kamakura S., Roden D.M., and Wilde A.A. Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 113 (2006) 338-344
70. Weiss R., Barmada M.M., Nguyen T., Seibel J.S., Cavlovich D., Kornblit C.A., Angelilli A., Villanueva F., McNamara D.M., and London B. Clinical and molecular heterogeneity in the Brugada syndrome. A novel gene locus on chromosome 3. Circulation 105 (2002) 707-713
71. London B., Sanyal S., Michalec M., Pfahnl A.E., Shang L.L., Kerchner B.S., Lagana S., Aleong R.G., Mehdi H., Gutmann R., Weiss R., and Dudley S.C. AB16-1: a mutation in the glycerol-3-phosphate dehydrogenase 1-like gene (GPD1L) causes Brugada syndrome. Heart Rhythm 3 (2006) S32
72. Antzelevitch C., Pollevick G.D., Cordeiro J.M., Casis O., Sanguinetti M.C., Aizawa Y., Guerchicoff A., Pfeiffer R., Oliva A., Wollnik B., Gelber P., Bonaros Jr. E.P., Burashnikov E., Wu Y., Sargent J.D., Schickel S., Oberheiden R., Bhatia A., Hsu L.F., Haissaguerre M., Schimpf R., Borggrefe M., and Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT Intervals, and sudden cardiac death. Circulation 115 (2007) 442-449
73. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 12 (2001) 268-272
74. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 29 (2006) 1130-1159
75. Gussak I., Antzelevitch C., Bjerregaard P., Towbin J.A., and Chaitman B.R. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 33 (1999) 5-15
76. Tukkie R., Sogaard P., Vleugels J., De Groot I.K., Wilde A.A., and Tan H.L. Delay in right ventricular activation contributes to Brugada syndrome. Circulation (2004) 1272-1277
77. Yan G.X., and Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 100 (1999) 1660-1666
78. Lukas A., and Antzelevitch C. Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. Cardiovasc Res 32 (1996) 593-603
79. Fish J.M., and Antzelevitch C. Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 1 (2004) 210-217
80. Aiba T., Shimizu W., Hidaka I., Uemura K., Noda T., Zheng C., Kamiya A., Inagaki M., Sugimachi M., and Sunagawa K. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. J Am Coll Cardiol 47 (2006) 2074-2085
81. Morita H., Zipes D.P., Lopshire J., Morita S.T., and Wu J. T wave alternans in an in vitro canine tissue model of Brugada syndrome. Am J Physiol Heart Circ Physiol 291 (2006) H421-H428
82. Morita H., Zipes D.P., Morita S.T., and Wu J. Temperature modulation of ventricular arrhythmogenicity in a canine tissue model of Brugada syndrome. Heart Rhythm 4 (2007) 188-197
83. Antzelevitch C., Brugada P., Brugada J., Brugada R., Shimizu W., Gussak I., and Perez Riera A.R. Brugada syndrome. A decade of progress. Circ Res 91 (2002) 1114-1119
84. Kurita T., Shimizu W., Inagaki M., Suyama K., Taguchi A., Satomi K., Aihara N., Kamakura S., Kobayashi J., and Kosakai Y. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 40 (2002) 330-334
85. Gussak I., Brugada P., Brugada J., Wright R.S., Kopecky S.L., Chaitman B.R., and Bjerregaard P. Idiopathic short QT interval: a new clinical syndrome?. Cardiology 94 (2000) 99-102
86. Gussak I., Brugada P., Brugada J., Antzelevitch C., Osbakken M., and Bjerregaard P. ECG phenomenon of idiopathic and paradoxical short QT intervals. Cardiac Electrophysiol Rev 6 (2002) 49-53
87. Gaita F., Giustetto C., Bianchi F., Wolpert C., Schimpf R., Riccardi R., Grossi S., Richiardi E., and Borggrefe M. Short QT syndrome: a familial cause of sudden death. Circulation 108 (2003) 965-970
88. Brugada R., Hong K., Dumaine R., Cordeiro J.M., Gaita F., Borggrefe M., Menendez T.M., Brugada J., Pollevick G.D., Wolpert C., Burashnikov E., Matsuo K., Wu Y.S., Guerchicoff A., Bianchi F., Giustetto C., Schimpf R., Brugada P., and Antzelevitch C. Sudden death associated with short QT-syndrome linked to mutations in HERG. Circulation 109 (2004) 30-35
89. Bellocq C., Van Ginneken A.C., Bezzina C.R., Alders M., Escande D., Mannens M.M., Baro I., and Wilde A.A. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109 (2004) 2394-2397
90. Extramiana F., and Antzelevitch C. Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome. Circulation 110 (2004) 3661-3666
91. Leenhardt A., Lucet V., Denjoy I., Grau F., Ngoc D.D., and Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91 (1995) 1512-1519
92. Swan H., Piippo K., Viitasalo M., Heikkila P., Paavonen T., Kainulainen K., Kere J., Keto P., Kontula K., and Toivonen L. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 34 (1999) 2035-2042
93. Priori S.G., Napolitano C., Memmi M., Colombi B., Drago F., Gasparini M., DeSimone L., Coltorti F., Bloise R., Keegan R., Cruz Filho F.E., Vignati G., Benatar A., and DeLogu A. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106 (2002) 69-74
94. Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R., Sorrentino V., and Danieli G.A. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103 (2001) 196-200
95. Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M., Brahmbhatt B., Donarum E.A., Marino M., Tiso N., Viitasalo M., Toivonen L., Stephan D.A., and Kontula K. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103 (2001) 485-490
96. Postma A.V., Denjoy I., Hoorntje T.M., Lupoglazoff J.M., Da Costa A., Sebillon P., Mannens M.M., Wilde A.A., and Guicheney P. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res 91 (2002) e21-e26
97. Nam G.-B., Burashnikov A., and Antzelevitch C. Cellular mechanisms underlying the development of catecholaminergic ventricular tachycardia. Circulation 111 (2005) 2727-2733
98. Akar F.G., and Rosenbaum D.S. Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res 93 (2003) 638-645
99. Akar F.G., and Tomaselli G.F. Conduction abnormalities in nonischemic dilated cardiomyopathy: basic mechanisms and arrhythmic consequences. Trends Cardiovasc Med 15 (2005) 259-264
100. Vos M.A., and Jungschleger J.G. Transmural repolarization gradients in vivo: the flukes and falls of the endocardium. Cardiovasc Res 50 (2001) 423-425
101. van Opstal J.M., Verduyn S.C., Leunissen H.D., De Groot S.H., Wellens H.J., and Vos M.A. Electrophysiological parameters indicative of sudden cardiac death in the dog with chronic complete AV-block. Cardiovasc Res 50 (2001) 354-361
102. Yan G.X., Joshi A., Guo D., Hlaing T., Martin J., Xu X., and Kowey P.R. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation 110 (2004) 1036-1041
103. Di Diego J.M., and Antzelevitch C. Cellular basis for ST-segment changes observed during ischemia. J Electrocardiol 36 Suppl (2003) 1-5
104. Antzelevitch C. The Brugada syndrome: diagnostic criteria and cellular mechanisms. Eur Heart J 22 (2001) 356-363